ASTX660-01: Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas

May 24, 2018
https://clinicaltrials.gov/ct2/show/NCT02503423
Cancer - Lymphoma, Cancer - Sarcoma, Solid Tumors
Principal Investigator: Ding Wang, MD
cervical cancer, solid tumors, T-cell lymphoma, Non-Hodgkin's lymphoma, sarcoma, advanced cancer, cancer
Accepting Participants